This report includes a review of the potential for gene expression analyses to provide new information for solving problems in skeletal repair and regeneration. It focuses on two approaches: high-throughput gene array methods and representational difference analysis (RDA). The principles underlying these methods are presented with experimental tutorials and some applications. Second, this report includes a review of results from applying both approaches to an in vitro model of postnatal chondroinduction by demineralized bone powder (DBP). Human dermal fibroblasts (hDFs) cultured with DBP acquire a chondroblast phenotype and express cartilage-specific matrix proteins after 7 days. We used cDNA macroarrays and RDA to identify the genes that were altered prior to expression of the chondroblast phenotype, i.e., after only 3 days’ culture with DBP. Using a strategy of data management and reduction based upon biological functions, we reported several functional families of genes (cytoskeletal elements, protein synthesis/trafficking, and matrix molecules and their modifiers) that are upregulated during chondroinduction of hDFs. Together with histological and biochemical evidence of the chondroblast phenotype, the gene expression patterns indicate that there are specific stages of induced chondrocyte differentiation in this experimental system. Third, this report includes a new study, in which DBP-regulated genes were used as a data base to derive new information on the cell biology of chondrocytes. The objective was to determine whether a set of genes expressed during induction of chondrocyte differentiation is also expressed by mature articular chondrocytes. Our search of the literature for 59 of the DBP-regulated genes disclosed that expression of 20 of them (33%) had been documented in mature cartilage or chondrocytes. Of the 39 genes not previously documented in cartilage, 11 were tested by RT-PCR and all were found to be expressed in freshly isolated adult human chondrocytes. This review and these new data show how the strategy of high-throughput methods and functional data reduction can expand our knowledge of chondrocyte cell biology.

1.
Aigner, T., A. Zien, A. Gehrsitz, P.M. Gebhard, L. McKenna (2001) Anabolic and catabolic gene expression pattern analysis in normal versus osteoarthritic cartilage using complementary DNA-array technology. Arthritis Rheum 44: 2777–2789.
2.
Alizadeh, A.A., M.B. Eisen, R.E. Davis, et al. (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403: 503–511.
3.
Altschul, S.F., T.L. Madden, A.A. Schaffer, et al. (1997) Gapped BLAST and PPSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res 25: 3389–3402.
4.
Armstrong, S.A., A.L. Kung, M.E. Mabon, et al. (2003) Inhibition of FLT3 in MLL. Validation of a therapeutic target identified by gene expression based classification. Cancer Cell 3: 173–183.
5.
Armstrong, S.A., J.E. Staunton, L.B. Silverman, et al. (2002) MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet 30: 41–47.
6.
Balint, E., D. Lapointe, H. Drissi, et al. (2003) Phenotype discovery by gene expression profiling: Mapping of biological processes linked to BMP-2 mediated osteoblast differentiation. J Cell Biochem 89: 401–426.
7.
Bargoni, N., O. Tazartes (1988) Polyamines and enzymes of polyamines metabolism in the cartilage during embryonic development. Int J Biochem 20: 317–319.
8.
Benya, P.D., J.D. Shaffer (1982) Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels. Cell 30: 215–224.
9.
Benz, K., S. Breit, M. Lukoschek, H. Mau, W. Richter (2002) Molecular analysis of expression, differentiation, and growth factor treatment of human chondrocytes identifies differentiation markers and growth-related genes. Biochem Biophys Res Commun 293: 284–292.
10.
Bergemann, G., N. Paricio, R. Artero, I. Kiss, M. Perez-Alonso, M. Mlodzik (1997) Muscleblind, a gene required for photoreceptor differentiation in Drosophila, encodes novel nuclear Cys3His-type zinc-finger-containing proteins. Development 124: 4321–4331.
11.
Billings, P.C., D.J. Herrick, U. Kucich, et al. (2000) Extracellular matrix and nuclear localization of βig-h3 in human bladder smooth muscle and fibroblast cells. J Cell Biochem 79: 261–273.
12.
Bland, Y.S., D.E. Ashurst (1996) Development and ageing of the articular cartilage of the rabbit knee joint: Distribution of the fibrillar collagens. Anat Embryol 194: 607–619.
13.
Braun, B.S., R. Frieden, S.L. Lessnick, W.A. May, C.T. Denny (1995) Identification of target genes for the Ewing’s sarcoma EWS/FLI fusion protein by representational difference analysis. Mol Cell Biol 15: 4623–4630.
14.
Chang, D.D., C. Denny (1998) Isolating differentially expressed genes by representational difference analysis; in Seibert, P.D. (ed): RT-PCR Methods for Gene Cloning and Analysis. Natick, Eaton Publishing, pp. 193–202.
15.
Chang, D.D., N.-H. Park, C.T. Denny, S.F. Nelson, M. Pe (1998) Characterization of transformation related genes in oral cancer cells. Oncogene 16: 1921–1930.
16.
Chang, Y. (2002) Representational difference analysis; in Current Protocols in Molecular Biology. Chichester, Wiley, suppl. 60, pp. 25B.7.1–12.
17.
Clemmensen, I., B. Holund, N. Johansen, R.B. Andersen (1982) Demonstration of fibronectin in human articular cartilage by an indirect immunoperoxidase technique. Histochemistry 76: 51–56.
18.
Dieudonné, S.C., J.M. Kerr, T. Xu, et al. (1999) Differential display of human marrow stromal cells reveals unique mRNA expression patterns in response to dexamethasone. J Cell Biochem 76: 231–243.
19.
Dodds, R.A., K. Merry, A. Littlewood, M. Gowen (1994) Expression of mRNA for IL1β, IL6 and TGF beta 1 in developing human bone and cartilage. J Histochem Cytochem 42: 733–744.
20.
Druker, B.J., C.L. Sawyers, H. Kantarjian, et al. (2001a) Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N Engl J Med 344: 1038–1042.
21.
Druker, B.J., M. Talpaz, D.J. Resta, et al. (2001b) Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 344: 1031–1037.
22.
Dürr J., P. Lammi, S.L. Goodman, T. Aigner, K. von der Mark (1996) Identification and immunolocalization of laminin in cartilage. Exp Cell Res 222: 225–233.
23.
Fardaei, M., M.T. Rogers, H.M. Thorpe, et al. (2002) Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells. Hum Mol Genet 11: 805–814.
24.
Frohme, M., B. Scharm, H. Delius, R. Knecht, J. Hoheisel (2000) Use of representational difference analysis and cDNA arrays for transcriptional profiling of tumor tissue. Ann NY Acad Sci 910: 85–104.
25.
Furuto, D.K., R.E. Gay, T.E. Stewart, E.J. Miller, S. Gay (1991) Immunolocalization of types V and XI collagen in cartilage using monoclonal antibodies. Matrix 11: 144–149.
26.
Glowacki, J. (1996) Cellular reactions to bone-derived material. Clin Orthop 324: 47–54.
27.
Glowacki, J., L.B. Kaban, J.E. Murray, J. Folkman, J.B. Mulliken (1981) Application of the biological principle of induced osteogenesis for craniofacial defects. Lancet i: 959–963.
28.
Glowacki, J., E. Trepman, J. Folkman (1983) Cell shape and phenotypic expression in chondrocytes. Proc Soc Exp Biol Med 172: 93–98.
29.
Glowacki, J., K. Yates, G. Little, S. Mizuno (1998) Induced chondroblastic differentiation of human dermal fibroblasts by three-dimensional culture with demineralized bone matrix. Mat Sci Eng C 6: 199–203.
30.
Glowacki, J., S. Zhou, K.E. Yates (2003) Comparison of TGF-β/BMP pathways signaled by BMP-2 and demineralized bone powder in human dermal fibroblasts. J Bone Miner Res, 18: S184.
31.
Golling, G., A. Amsterdam, Z. Sun, et al. (2002) Insertional mutagenesis in zebrafish rapidly identifies genes essential for early vertebrate development. Nat Genet 31: 135–140.
32.
Golub, T.R., D.K. Slonim, P. Tamayo, et al. (1999) Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring. Science 286: 531–537.
33.
Grzybowska, E.A., A. Wilczynska, J.A. Siedlecki (2001) Regulatory functions of 3′ UTRs. Biochem Biophys Res Commun 288: 291–295.
34.
Hanspal, M., Y. Smockova, Q. Uong (2000) Molecular identification and functional characterization of a novel protein that mediates the attachment of erythroblasts to macrophages. Blood 92: 2940–2950.
35.
Hashimoto, K., M. Noshiro, S. Ohno, et al. (1997) Characterization of a cartilage-derived 66-kDa protein (RGD-CAP/βig-h3) that binds to collagen. Biochim Biophys Acta 1355: 303–314.
36.
Haudenschild, D.R., J.M. McPherson, R. Tuno, F. Binette (2001) Differential expression of multiple genes during articular chondrocyte redifferentiation. Anat Rec 263: 91–98.
37.
Hedenfalk, I., M. Rignér, A. Ben-Dor, et al. (2003) Molecular classification of familial non-BRCA1/BRCA2 breast cancer. Proc Natl Acad Sci USA 100: 2532–2537.
38.
Hubank, M., D.G. Schatz (1994) Identifying differences in mRNA expression by representational difference analysis of cDNA. Nucleic Acids Res 22: 5640–5648.
39.
Hubank, M., D. Schatz (1999) cDNA representational difference analysis: A sensitive and flexible method for identification of differentially expressed genes. Methods Enzymol 303: 325–349.
40.
Ismail, R. R.L. Baldwin, J. Fang, et al. (2000) Differential gene expression between normal and tumor-derived ovarian epithelial cells. Cancer Res 60: 6744–6749.
41.
Jen, Y., K. Manova, R. Benezra (1996) Expression patterns of Id1, Id2, and Id3 are highly related but distinct from that of Id4 during mouse embryogenesis. Dev Dyn 207: 235–252.
42.
Kawamoto, T., M. Noshiro, M. Shen, et al. (1998) Structural and phylogenetic analyses of RGD-CAP/βig-h3, a fasciclin-like adhesion protein expressed in chick chondrocytes. Biochim Biophys Acta 1395: 288–292.
43.
Kelly, D.L., A. Rizzino (2000) DNA microarray analyses of genes regulated during the differentiation of embryonic stem cells. Mol Reprod Dev 56: 113–123.
44.
Kikuchi, T., Y. Daigo, T. Katagiri, et al. (2003) Expression profiles of non-small cell lung cancers on cDNA microarrays: Identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs. Oncogene 22: 2192–2205.
45.
LeBaron, R.G., K.I. Bezverkov, M.P. Zimber, R. Pavelec, J. Skonier, A.F. Purchio (1995) βIG-H3, a novel secretory protein inducible by transforming growth factor-β, is present in normal skin and promotes the adhesion and spreading of dermal fibroblasts in vitro. J Invest Dermatol 104: 844–849.
46.
Leistad, L., M. Østensen, A. Faxvaag (1998) Detection of cytokine mRNA in human, articular cartilage from patients with rheumatoid arthritis and osteoarthritis by reverse transcriptase-polymerase chain reaction. Scand J Rheumatol 27: 61–67.
47.
Lewinson, D., A. Boskey (1984) Calmodulin localization in bone and cartilage. Cell Biol Int Rep 8: 11–18.
48.
Liang, P. (2002) A decade of differential display. Biotechniques 33: 338–346.
49.
Lisitsyn, N., N. Lisitsyn, M. Wigler (1993) Cloning the differences between two complex genomes. Science 259: 946–951.
50.
Mangham, D.C., A. Cannon, S. Komiya, et al. (1996) P-glycoprotein is expressed in the mineralizing regions of the skeleton. Calcif Tissue Int 58: 186–191.
51.
Miyashi, O., K. Sakata, M. Matsuyama, S. Saga (1992) Distribution of the collagen binding heat-shock protein in chicken tissues. J Histochem Cytochem 40: 1021–1029.
52.
Mizuno, S., J. Glowacki (1996a) Chondroinduction of human dermal fibroblasts by demineralized bone in three-dimensional culture. Exp Cell Res 227: 89–97.
53.
Mizuno, S., J. Glowacki (1996b) Three-dimensional composite of demineralized bone powder and collagen for in vitro analysis of chondroinduction of human dermal fibroblasts. Biomaterials 17: 1819–1825.
54.
Mollenhauer, J., M.T. Mok, K.B. King, et al. (1999) Expression of anchorin CII (cartilage annexin V) in human young, normal adult, and osteoarthritic cartilage. J Histochem Cytochem 47: 209–220.
55.
Moos, V., S. Fickert, B. Müller, U. Weber, J. Sieper (1999) Immunohistological analysis of cytokine expression in human osteoarthritic and healthy cartilage. J Rheumatol 26: 870–879.
56.
O’Brien, T.P., L.F. Lau (1992) Expression of the growth factor-inducible immediate early gene cyr61 correlates with chondrogenesis during mouse embryonic development. Cell Growth Differ 3: 645–654.
57.
Olney, R.C., D.M. Wilson, M. Mohtai, P.J. Fielder, R.L. Smith (1995) Interleukin-1 and tumor necrosis factor-alpha increase insulin-like growth factor-binding protein-3 (IGFBP-3) production and IGFBP-3 protease activity in human articular chondrocytes. J Endocrinol 146: 279–286.
58.
Olney, R.C., K. Tsuchiya, D.M. Wilson, et al. (1996) Chondrocytes from osteoarthritic cartilage have increased expression of insulin-like growth factor I (IGF-I) and IGF-binding protein-3 (IGFBP-3) and -5, but not IGF-II or IGFBP-4. J Clin Endocrinol Metab 81: 1096–1103.
59.
Paulsen, F., B. Tillmann (1999) Composition of the extracellular matrix in human cricoarytenoid joint articular cartilage. Arch Histol Cytol 62: 149–163.
60.
Pesole, G., F. Mignone, C. Gissi, G. Grillo, F. Licciulli, S. Liuni (2001) Structural and functional features of eukaryotic mRNA untranslated regions. Gene 276: 73–81.
61.
Pfander, D., T. Cramer, D. Deuerling, G. Weseloh, B. Swoboda (2000) Expression of thrombospondin-1 and its receptor CD36 in human osteoarthritic cartilage. Ann Rheum Dis 59: 448–454.
62.
Plenz, G., S. Kügler, S. Schnittger, H. Rieder, C. Fonatsch, P.K. Müller (1994) The human vigilin gene: Identification, chromosomal localization and expression pattern. Hum Genet 93: 575–582.
63.
Poole, C.A., S. Ayad, J.R. Schofield (1988) Chondrons from articular cartilage. I. Immunolocalization of type VI collagen in the pericellular capsule of isolated canine tibial chondrons. J Cell Sci 90: 635–643.
64.
Ramaswamy, S., T.R. Golub (2002) DNA microarrays in clinical oncology. J Clin Oncol 20: 1932–1941.
65.
Reddi, A. H., C.B. Huggins (1972) Biochemical sequences in the transformation of normal fibroblasts in adolescent rats. Proc Natl Acad Sci USA 69: 1601–1605.
66.
Rosenberg, L.C., H.U. Choi, L.-H. Tang, et al. (1985) Isolation of dermatan sulfate proteoglycans from mature bovine articular cartilages. J Biol Chem 260: 6304–6313.
67.
Rosenthal, R.K., J. Folkman, J. Glowacki (1999) Demineralized bone implants for non-union fractures, bone cysts, and fibrous bone lesions. Clin Orthop 364: 61–69.
68.
Rosier, R.N., R.J. O’Keefe, L.A. Teot, et al. (1997) P-glycoprotein expression in cartilaginous tumors. J Surg Oncol 65: 95–105.
69.
Rozen, S., H.J. Skaletsky (1998). Primer3. Code available at http://www-genome.wi.mit.edu/cgi-bin/primer/primer3_www.cgi.
70.
Sakai, L.Y., D.R. Keene, E. Engvall (1986) Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils. J Cell Biol 103: 2499–2509.
71.
Salter, D.M., D.E. Hughes, R. Simpson, D.L. Gardner (1992) Integrin expression by human articular chondrocytes. Br J Rheumatol 31: 231–234.
72.
Sampson, H.W., M.S. Cannon (1986) Zonal analysis of metabolic profiles of articular-epiphyseal cartilage chondrocytes: A histochemical study. Histochem J 18: 233–238.
73.
Sandberg, M., E. Vuorio (1987) Localization of types I, II, and III collagen mRNAs in developing human skeletal tissues by in situ hybridization. J Cell Biol 104: 1077–1084.
74.
Saras, J., P. Franzen, P. Aspenstrom, U. Hellman, L.J. Gonez, C.H. Heldin (1997) A novel GTPase-activating protein for Rho interacts with a PDZ domain of the protein-tyrosine phosphatase PTPL1. J Biol Chem 272: 24333–24338.
75.
Sekiya, I., J.T. Vuoristo, B.N. Larson, D.J. Prockop (2002) In vitro cartilage formation by human adult stem cells from bone marrow stroma defines the sequences of cellular and molecular events during chondrogenesis. Proc Natl Acad Sci USA 99: 4397–4402.
76.
Shipp, M.A., K.N. Ross, P. Tamayo, et al. (2002) Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med 8: 68–74.
77.
Simon, H.U., G.B. Mills, M. Kozlowski, et al. (1994) Molecular characterization of hNRP, a cDNA encoding a human nucleosome-assembly-protein-I-related gene product involved in the induction of cell proliferation. Biochem J 297: 389–397.
78.
Skonier, J., K. Bennett, V. Rothwell, et al. (1994) Beta ig-h3: A transforming growth factor-beta-responsive gene encoding a secreted protein that inhibits cell attachment in vitro and suppresses the growth of CHO cells in nude mice. DNA Cell Biol 13: 571–584.
79.
Skonier, J., M. Nerbauer, L. Madisen, K. Bennett, G.D. Plowman, A.F. Purchio (1992) cDNA cloning and sequence analysis of βig-h3, a novel gene induced in a human adenocarcinoma cell line after treatment with transforming growth factor-β. DNA Cell Biol 11: 511–522.
80.
Slamon, D.J., B. Leyland-Jones, S. Shak, et al. (2001) Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 344: 783–792.
81.
Sonis, S.T., L.B. Kaban, J. Glowacki (1983) Clinical trial of demineralized bone powder in the treatment of periodontal defects. J Oral Med 38: 117–121.
82.
Stassen, F.L.H. (1976) Properties of highly purified lysyl oxidase from embryonic chick cartilage. Biochim Biophys Acta 438: 49–60.
83.
Stebbings, H. (2001) Cytoskeleton-dependent transport and localization of mRNA. Int Rev Cytol 211: 1–31.
84.
Tajima, Y., M. Kawasaki, K. Kurihara, T. Ueha, S. Yokose (1998) Immunohistochemical profile of basic fibroblasts growth factor and heparan sulphate in adult rat mandibular condylar cartilage. Arch Oral Biol 43: 873–877.
85.
Takahashi, K., T. Kubo, R.S. Goomer, et al. (1997) Analysis of heat shock proteins and cytokines expressed during early stages of osteoarthritis in a mouse model. Osteoarthritis Cartilage 5: 321–329.
86.
Tevosian, S.G., A.E. Deconinck, M. Tanaka, et al. (2000) FOG-2, a cofactor for GATA transcription factors, is essential for heart morphogenesis and development of coronary vessels from epicardium. Cell 101: 729–739.
87.
Upton, J., J. Glowacki J (1992) Hand reconstruction with allograft demineralized bone: 26 implants in 12 patients. J Hand Surg 17A: 704–713.
88.
Urist, M.R., E. Dawson (1981) Intertransverse process fusion with the aid of chemosterilized autolyzed antigen-extracted allogeneic (AAA) bone. Clin Orthop 154: 97–113.
89.
van ‘t Veer, L.J., H. Dal, M.J. van de Vijver, et al. (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415: 530–536.
90.
Welford, S.M., J. Gregg, E. Chen, et al. (1998) Detection of differentially expressed genes in primary tumor tissues using representational differences analysis coupled to microarray hybridization. Nucleic Acids Res 26: 3059–3065.
91.
Widelitz, R.B., T.X. Jiang, B.J. Murray, C.M. Chuong (1993) Adhesion molecules in skeletogenesis. II. Neural cell adhesion molecules mediate precartilaginous mesenchymal condensations and enhance chondrogenesis. J Cell Physiol 156: 399–411.
92.
Yamamoto, Y., H. Kiyoi, Y. Nakano, et al. (2001) Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies. Blood 97: 2434–2439.
93.
Yates, K.E. (2004) Inferred functions of ‘novel’ genes identified in fibroblasts chondroinduced by demineralized bone powder. DNA Cell Biol, in press.
94.
Yates, K.E., J. Glowacki (2003a) Altered expression of connective tissue genes in postnatal chondroinduced human dermal fibroblasts. Connect Tissue Res 44: 121–127.
95.
Yates, K.E., J. Glowacki (2003b) Gene expression changes in an in vitro model of chondroinduction: a comparison of two methods. Wound Repair Regen 11: 386–392.
96.
Yates, K.E., S. Mizuno, J. Glowacki (2001) Early shifts in gene expression during chondroinduction of human dermal fibroblasts. Exp Cell Res 265: 203–211.
97.
Yates, K.E., S. Zhou, J. Glowacki (2003) Genes that influence cell differentiation are altered by demineralized bone in vitro. J Bone Miner Res 18: S192.
98.
Yeowell, H.N., L.C. Walker (1999) Tissue specificity of a new splice form of the human lysyl hydroxylase 2 gene. Matrix Biol 19: 179–187.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.